3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Gastrointestinal
1
Conditions
Breast Neoplasms
665
Neoplasms
585
Colorectal Neoplasms
291
Carcinoma, Non-Small-Cell Lung
289
Prostatic Neoplasms
277
Lung Neoplasms
217
Melanoma
159
Multiple Myeloma
149
Neoplasm Metastasis
145
Head and Neck Neoplasms
143
Pancreatic Neoplasms
139
Ovarian Neoplasms
129
Carcinoma, Hepatocellular
126
Leukemia, Myeloid, Acute
121
Brain Neoplasms
111
Squamous Cell Carcinoma of Head and Neck
109
Colonic Neoplasms
109
Uterine Cervical Neoplasms
106
Stomach Neoplasms
102
Recurrence
101
Lymphoma
100
Glioblastoma
90
Lymphoma, Non-Hodgkin
82
Precursor Cell Lymphoblastic Leukemia-Lymphoma
78
Hematologic Neoplasms
78
Lymphoma, Follicular
77
Urinary Bladder Neoplasms
76
Parkinson Disease 4, Autosomal Dominant Lewy Body
74
Glioma
72
Sarcoma
70
Interventions
relatlimab
1
daratumumab
1
cobimetinib
1
Nivolumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Microsatellite Unstable Colorectal Cancer
×
1 year
×
Clear all
NCT02060188
2025-11-06
CheckMate142
Bristol-Myers Squibb
Phase 2
Completed
385 enrolled
17 charts
2 FDA